How malaria parasites exploit mechanism for escaping elimination could provide novel strategies targeting chronic malaria ...

In addition to complementing AAV manufacturing, the company’s Plasmid DNA (pDNA) platform is now available as a standalone service.

Treated with an individualized gene-editing therapy that corrects mutations directly on the genome, a patient shows ...

Estrogen-related receptors (ERRs) regulate muscle mitochondria in mice, revealing a new potential drug targets for metabolic ...

Researchers were able to test how viruses replicate differently across various bat species and organs using the new organoid ...

CEO Serge Saxonov, PhD, acknowledged that its R&D operation “definitely ended up being impacted in a substantial way” while ...

Imprint has raised $15 million to decode the body's immune memory for understanding chronic diseases, such as long-COVID and ...

Scientists say study findings indicate that TC IV cells may represent a therapeutic target for the treatment of food-associated allergic and inflammatory diseases.

Current setbacks cannot prevent gene-editing companies from advancing closer to “one-and-done” cures and new products.

Montreal-based Nomic Bio broadens its proteomics technology to offer a 1,000-plex protein measurement service.

Innovative delivery techniques, including high-tech nanoparticles and electroporationdevices, may convey more gene therapies ...

Results highlight importance of addressing overwork as an occupational health concern, and the need for workplace policies to ...